{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T11:20:16Z","timestamp":1772623216599,"version":"3.50.1"},"reference-count":38,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"AMC Graduate School","award":["n\/A"],"award-info":[{"award-number":["n\/A"]}]},{"name":"ONWAR imaging fund","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Purpose: The pathophysiology of cervical dystonia (CD) is thought to be related to changes in dopamine and serotonin levels in the brain. We performed a double-blind trial with escitalopram (selective serotonin reuptake inhibitor; SSRI) in patients with CD. Here, we report on changes in dopamine D2\/3 receptor (D2\/3R), dopamine transporter (DAT) and serotonin transporter (SERT) binding potential (BPND) after a six-week treatment course with escitalopram or placebo. Methods: CD patients had [123I]FP-CIT SPECT (I-123 fluoropropyl carbomethoxy-3 beta-(4-iodophenyltropane) single-photon emission computed tomography) scans, to quantify extrastriatal SERT and striatal DAT, and [123I]IBZM SPECT (I-123 iodobenzamide SPECT) scans to quantify striatal D2\/3R BPND before and after six weeks of treatment with either escitalopram or placebo. Treatment effect was evaluated with the Clinical Global Impression scale for dystonia, jerks and psychiatric symptoms, both by physicians and patients. Results: In both patients treated with escitalopram and placebo there were no significant differences after treatment in SERT, DAT or D2\/3R BPND. Comparing scans after treatment with escitalopram (n = 8) to placebo (n = 8) showed a trend (p = 0.13) towards lower extrastriatal SERT BPND in the SSRI group (median SERT occupancy of 64.6%). After treatment with escitalopram, patients who reported a positive effect on dystonia or psychiatric symptoms had significantly higher SERT occupancy compared to patients who did not experience an effect. Conclusion: Higher extrastriatal SERT occupancy after treatment with escitalopram is associated with a trend towards a positive subjective effect on dystonia and psychiatric symptoms in CD patients.<\/jats:p>","DOI":"10.3390\/biom10060880","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T06:34:16Z","timestamp":1591684456000},"page":"880","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Effect of Escitalopram on Central Serotonergic and Dopaminergic Systems in Patients with Cervical Dystonia, and Its Relationship with Clinical Treatment Effects: A Double-Blind Placebo-Controlled Trial"],"prefix":"10.3390","volume":"10","author":[{"given":"Evelien","family":"Zoons","sequence":"first","affiliation":[{"name":"Department of Neurology, Zaans Medisch Centrum, 1502 DV Zaandam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5783-571X","authenticated-orcid":false,"given":"Marina A.J.","family":"Tijssen","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Medical Centre, 9713 GZ Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2791-908X","authenticated-orcid":false,"given":"Yasmine E.M.","family":"Dreissen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Amsterdam University Medical Centre, Location Academic Medical Centre, 1100 DD Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marenka","family":"Smit","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Medical Centre, 9713 GZ Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Booij","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Amsterdam UMC, Location Academic Medical Centre, 1100 DD Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,6,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMra055549","article-title":"Dystonia","volume":"355","author":"Tarsy","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.parkreldis.2013.02.017","article-title":"Tremulous cervical dystonia is likely to be familial: Clinical characteristics of a large cohort","volume":"19","author":"Parees","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.NMD.0000081667.02656.21","article-title":"High psychiatric comorbidity in spasmodic torticollis: A controlled study","volume":"191","author":"Gundel","year":"2003","journal-title":"J. Nerv. Ment. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.parkreldis.2016.06.004","article-title":"Psychiatric co-morbidity is highly prevalent in idiopathic cervical dystonia and significantly influences health-related quality of life: Results of a controlled study","volume":"30","author":"Smit","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_5","first-page":"163","article-title":"Dysfunction of dopaminergic pathways in dystonia","volume":"94","author":"Perlmutter","year":"2004","journal-title":"Adv. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neubiorev.2016.03.015","article-title":"Serotonergic perturbations in dystonia disorders-a systematic review","volume":"65","author":"Smit","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00259-017-3664-x","article-title":"The relationship between the dopaminergic system and depressive symptoms in cervical dystonia","volume":"44","author":"Zoons","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13550-017-0338-4","article-title":"Lower serotonin transporter binding in patients with cervical dystonia is associated with psychiatric symptoms","volume":"7","author":"Zoons","year":"2017","journal-title":"EJNMMI Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0278-5846(02)00338-X","article-title":"Role of selective serotonin reuptake inhibitors in psychiatric disorders: A comprehensive review","volume":"27","author":"Vaswani","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00213-006-0540-y","article-title":"Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: A 123I-ADAM SPECT study","volume":"189","author":"Catafau","year":"2006","journal-title":"Psychopharmacology (Berlin)"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.euroneuro.2014.12.010","article-title":"Altered serotonin and dopamine transporter availabilities in brain of depressed patients upon treatment with escitalopram: A [123 I]beta-CIT SPECT study","volume":"25","author":"Rominger","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2967\/jnumed.110.078337","article-title":"Serotonin transporters in dopamine transporter imaging: A head-to-head comparison of dopamine transporter SPECT radioligands 123I-FP-CIT and 123I-PE2I","volume":"51","author":"Ziebell","year":"2010","journal-title":"J. Nucl. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuroimage.2013.10.002","article-title":"Regional differences in SERT occupancy after acute and prolonged SSRI intake investigated by brain PET","volume":"88","author":"Baldinger","year":"2014","journal-title":"Neuroimage"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00213-006-0666-y","article-title":"Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: An [123I]ADAM SPECT study","volume":"191","author":"Klein","year":"2007","journal-title":"Psychopharmacology (Berlin)"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00259-008-1057-x","article-title":"Serotonin transporter binding with [123I]beta-CIT SPECT in major depressive disorder versus controls: Effect of season and gender","volume":"36","author":"Ruhe","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/npp.2008.148","article-title":"Evidence why paroxetine dose escalation is not effective in major depressive disorder: A randomized controlled trial with assessment of serotonin transporter occupancy","volume":"34","author":"Ruhe","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Zoons, E., Booij, J., Delnooz, C.C.S., Dijk, J.M., Dreissen, Y.E.M., Koelman, J., van der Salm, S.M.A., Skorvanek, M., Smit, M., and Aramideh, M. (2018). Randomised controlled trial of escitalopram for cervical dystonia with dystonic jerks\/tremor. J. Neurol. Neurosurg Psychiatry.","DOI":"10.1136\/jnnp-2017-317352"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00259-007-0621-0","article-title":"Dopamine transporter imaging with [(123)I]FP-CIT SPECT: Potential effects of drugs","volume":"35","author":"Booij","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/bmc.1542","article-title":"Analytical procedures for the determination of the selective serotonin reuptake inhibitor antidepressant citalopram and its metabolites","volume":"25","author":"Unceta","year":"2011","journal-title":"Biomed. Chromatogr."},{"key":"ref_20","first-page":"20","article-title":"Pretreatment status and its relationship to the length of drying-out period","volume":"12","author":"Guy","year":"1976","journal-title":"Psychopharmacol. Bull."},{"key":"ref_21","first-page":"753","article-title":"One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson\u2019s disease by [123I]FPCIT SPECT","volume":"40","author":"Booij","year":"1999","journal-title":"J. Nucl. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2967\/jnumed.111.102277","article-title":"Assessing the optimal time point for the measurement of extrastriatal serotonin transporter binding with 123I-FP-CIT SPECT in healthy, male subjects","volume":"53","author":"Koopman","year":"2012","journal-title":"J. Nucl. Med."},{"key":"ref_23","first-page":"1879","article-title":"Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson\u2019s disease","volume":"39","author":"Booij","year":"1998","journal-title":"J. Nucl. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S425","DOI":"10.1016\/S1353-8020(08)70042-7","article-title":"SPECT imaging of the dopaminergic system in (premotor) Parkinson\u2019s disease","volume":"13","author":"Booij","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_25","first-page":"674","article-title":"Assessment of endogenous dopamine release by methylphenidate challenge using iodine-123 iodobenzamide single-photon emission tomography","volume":"24","author":"Booij","year":"1997","journal-title":"Eur. J. Nucl. Med."},{"key":"ref_26","first-page":"1182","article-title":"SPECT imaging of striatal dopamine release after amphetamine challenge","volume":"36","author":"Laruelle","year":"1995","journal-title":"J. Nucl. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1007\/s00259-008-0739-8","article-title":"AMPT-induced monoamine depletion in humans: Evaluation of two alternative [123I]IBZM SPECT procedures","volume":"35","author":"Boot","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/jnnp.62.2.133","article-title":"[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson\u2019s disease","volume":"62","author":"Booij","year":"1997","journal-title":"J. Neurol. Neurosurg Psychiatry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.biopsych.2013.06.021","article-title":"Deep brain stimulation induces striatal dopamine release in obsessive-compulsive disorder","volume":"75","author":"Figee","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","article-title":"Consensus nomenclature for in vivo imaging of reversibly binding radioligands","volume":"27","author":"Innis","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_31","first-page":"359","article-title":"Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: A double-blind, placebo-controlled, crossover study in healthy control subjects","volume":"48","author":"Booij","year":"2007","journal-title":"J. Nucl. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1007\/s00259-014-2785-8","article-title":"Extrastriatal binding of [(1)(2)(3)I]FP-CIT in the thalamus and pons: Gender and age dependencies assessed in a European multicentre database of healthy controls","volume":"41","author":"Koch","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_33","first-page":"1129","article-title":"SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT","volume":"37","author":"Gandelman","year":"1996","journal-title":"J. Nucl. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/sj.npp.1301290","article-title":"[123I]-beta-CIT SPECT imaging shows reduced thalamus-hypothalamus serotonin transporter availability in 24 drug-free obsessive-compulsive checkers","volume":"32","author":"Zitterl","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"ref_35","first-page":"86","article-title":"Imaging the serotonin transporter during major depressive disorder and antidepressant treatment","volume":"32","author":"Meyer","year":"2007","journal-title":"J. Psychiatry Neurosci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1176\/ajp.154.4.490","article-title":"Serotonergic modulation of dopamine measured with [11C]raclopride and PET in normal human subjects","volume":"154","author":"Smith","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0925-4927(99)00009-8","article-title":"Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT","volume":"90","author":"Klimke","year":"1999","journal-title":"Psychiatry Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/ejn.13390","article-title":"The dopamine D3 receptor, a quarter century later","volume":"45","author":"Sokoloff","year":"2017","journal-title":"Eur. J. Neurosci."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/10\/6\/880\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:36:45Z","timestamp":1760175405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/10\/6\/880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,8]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["biom10060880"],"URL":"https:\/\/doi.org\/10.3390\/biom10060880","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,8]]}}}